Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare genetic syndrome characterized by mild to severe global developmental delay, intellectual disability and behavioral abnormalities, hypotonia, strabismus, optic nerve hypoplasia and mild facial dysmorphic features (down slanting palpebral fissures, frontal bossing, crowded teeth, auricular abnormalities and prominent philtral ridges). Other associated clinical features may include seizures and skeletal anomalies (kyphosis/scoliosis, pectus deformities).
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for developmental and speech delay due to SOX5 deficiency.
3 publications have been identified in PubMed for developmental and speech delay due to SOX5 deficiency. Research spans Other (33%), Clinical Trial Publication (33%), and Epidemiology / Natural History (33%).
Veronese A (2025). [PMID: 39821785](https://pubmed.ncbi.nlm.nih.gov/39821785/). *Neuropediatrics*. [Other]
Kava H (2025). [PMID: 40083435](https://pubmed.ncbi.nlm.nih.gov/40083435/). *Front Pediatr*. [Clinical Trial Publication]
Yang X (2025). [PMID: 39905544](https://pubmed.ncbi.nlm.nih.gov/39905544/). *Orphanet J Rare Dis*. [Epidemiology / Natural History]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:50 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center